In silico investigations on HSP90 and its inhibition for the therapeutic prevention of breast cancer

Based on the protein-ligand docking results and drug-likeness of various molecules (Lipinski's filter criteria) selected for studying their inhibitory action over Hsp90, we found that 17-DMAG can be used into further investigations as a therapeutic molecule for breast cancer.